By predicting how medications would be metabolized, clinicians were able to avoid medicines that had a high likelihood of causing negative side effects.
VA Study Shows That Pharmacogenomic Testing Improves Outcomes With Depression Treatments Read More »
New rapid pharmacogenomic point-of-care genetic test for preventing deafness in babies begins clinical use.
Raises questions about what education and training is necessary for community, hospital, and health system pharmacists and other clinicians supporting pharmacogenomics.
With a focus on pharmacogenomics testing, proposed legislation would boost public demand for precision medicine treatments and build better electronic infrastructure to support precision medicine.
The adoption of a precision medicine program by such a large insurer is expected to significantly expand the availability of precision medicine options within the state.
Blue Care Network of Michigan to Launch Pharmacogenomic Personalized Medicine Program Read More »
Illegal financial underpinnings brought charges in a large conspiracy involving iIllicit payment schemes for certain kinds of precision medicine testing.
New research from Aarhus University, recently published in Translational Psychiatry, analyzed the frequency of genetic variations that affect drug metabolism and drug targets in over 77,000 patients. What the study found.
